1. Fig.1. The dose of GH administered to patients in different age groups after 1 year of GH replacement therapy. Data are shown as mean, median and 10th-90th percentiles
Females
Males
n=259 n=171 n=113 n=52
n=217 n=199 n=163 n=83
0,8
0,8
0,6
0,6
GH dose (mg/day)
GH dose (mg/day)
0,4
0,4
0,2
0,2
p<0,05
p<0,05
< >65
< >65
Age group (years)
Age group (years)
Abbildung mod. nach Monson, 2003

2. Fig.2. IGF SDS in patients in different age groups after 1 year of GH replacement therapy. Data are shown as mean, median and 10th-90th percentiles.
Females
Males
n=188 n=125 n=73 n=40
n=146 n=145 n=199 n=65 3 3 2 2 1 1
IGF-1 SDS
IGF-1 SDS -1 -1 -2 -2
p<0,05
p<0,05 -3 -3
< >65
< >65
Age group (years)
Age group (years)
Abbildung mod. nach Monson, 2003